-Parties: The plaintiffs included Astellas Pharma Canada Inc.. The defendant was Mint Pharmaceuticals Inc.

-Subject Matter: This is a Federal Court action. The uploaded text identifies the nature of the proceeding as “Patented Medicines Regulations (PMDR) [Actions],” shows that the proceeding is to continue as a specially managed proceeding, and states that Associate Judge Trent Horne was assigned as case management judge. The case is ongoing.

-Date: The hearing was set on June 17, 2026.

-Venue: This was a federal case before the Federal Court.

-Amount: No financial award was specified.